US2021292796A1PendingUtilityA1

Means and Methods for Generating Complex Glycans Derived From Fungal Engineered Hosts

60
Assignee: VIB VZWPriority: May 3, 2016Filed: Feb 26, 2021Published: Sep 23, 2021
Est. expiryMay 3, 2036(~9.8 yrs left)· nominal 20-yr term from priority
A61K 38/1741C07K 14/54C12P 21/005C12P 21/00C12P 1/02C12Y 302/01096A61P 43/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present application relates to the field of glyco-engineering, more specifically to glycosylation-engineered fungal cells, more specifically glycosylation-engineered yeast cells, optimized to produce highly homogenous forms of complex N-glycans on recombinant proteins. The invention specifically relates to methods to obtain pharmaceutical compositions comprising recombinant glycoproteins which have homogenous forms of complex N-glycans. In addition, the invention relates to novel pharmaceutical compositions which result from the methods of the invention.

Claims

exact text as granted — not AI-modified
1 . A method of producing a composition comprising different glycoforms of a glycoprotein, the method comprising:
 contacting complex N-glycan glycoforms of the glycoprotein secreted from a fungal organism with an endoglucosaminidase enzyme;   wherein the endoglucosaminidase enzyme acts on the secreted N-glycan glycoforms of the glycoprotein to produce the composition comprising different glycoforms of a glycoprotein, the composition comprising:
 a glycoform comprising a complex N-glycan and 
 a glycoform comprising an N-glycan structure consisting of a single GlcNAc; and 
   wherein the glycoprotein is exogenous to the fungal organism.   
     
     
         2 . The method according to  claim 1 , wherein the contacting occurs during purification of the glycoprotein. 
     
     
         3 . The method according to  claim 1 , wherein the contacting occurs after purification of the glycoprotein. 
     
     
         4 . The method according to  claim 1 , wherein contacting with the endoglucosaminidase takes place at a high salt concentration. 
     
     
         5 . The method according to  claim 2 , wherein contacting with the endoglucosaminidase takes place at a high salt concentration. 
     
     
         6 . The method according to  claim 3 , wherein contacting with the endoglucosaminidase takes place at a high salt concentration. 
     
     
         7 . The method according to  claim 1 , wherein the fungal organism expresses at least one exogenous nucleic acid sequence encoding an enzyme needed for complex N-glycosylation and/or wherein the fungal organism does not express an enzyme involved in the production of high-mannose type structures, which enzyme is normally expressed in a wild type from of the fungal organism. 
     
     
         8 . The method according to  claim 1 , wherein the endoglucosaminidase enzyme is an endo-beta-N-acetylglucosaminidase of EC3.2.1.96. 
     
     
         9 . The method according to  claim 1 , wherein the composition further comprises a glycoform comprising a complex N-glycan that is different from the glycoform comprising a complex N-glycan.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.